Showing results (91-100 of 187) with videos related to
Sort By:
Pageof 19
Frontiers in Cardiovascular Medicine|September 30, 2022
Increased atherosclerotic plaque in AOC3 knock-out in ApoE-/- mice and characterization of AOC3 in atherosclerotic human coronary arteriesAnna Filip, Soraya Taleb, Rümeyza Bascetin, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2014
Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- miceSafa Mellak, Hafid Ait-Oufella, Bruno Esposito, et al.Stem Cells (Dayton, Ohio)|September 29, 2009
Adiponectinemia controls pro-angiogenic cell therapyPhilippe Eren, Stéphane Camus, Gianfranco Matrone, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 27, 2007
IAP survivin regulates atherosclerotic macrophage survivalOlivier P Blanc-Brude, Elisabeth Teissier, Yves Castier, et al.Journal of Lipid Research|May 26, 2012
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemiaKiyohito Arai, Alexina Orsoni, Ziad Mallat, et al.Circulation Research|October 4, 2003
Rho-associated protein kinase contributes to early atherosclerotic lesion formation in miceZiad Mallat, Andrea Gojova, Vincent Sauzeau, et al.Journal of the American College of Cardiology|February 20, 2007
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaquesAurélie S Leroyer, Hirotaka Isobe, Guy Lesèche, et al.Journal of the American Society of Nephrology : JASN|September 30, 2005
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failureNicolas Amabile, Alain P Guérin, Aurélie Leroyer, et al.The American Journal of Pathology|September 18, 2007
Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1Matthias Canault, Aurélie S Leroyer, Franck Peiretti, et al.Molecular Medicine (Cambridge, Mass.)|February 24, 2006
Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in miceStéphane Potteaux, Christophe Combadière, Bruno Esposito, et al.Pageof 19